Pfizer uses sophisticated technologies to comb through and analyze data that has been integrated from a variety of sources, such as clinical trials, genomics, and imaging, all in order to develop and test diagnostics and treatments for specific populations. Whether through sensors that deliver health data to clinicians or mobile apps that support patients through treatments, Pfizer is leveraging new methods of engagement and data capture, all of which support the research and development of new drugs. Partner with Complementary Organizations Through partnerships with other pharmaceutical, academic, and clinical organizations, Pfizer is able to leverage diverse talent on a much wider scale. These collaborations allow for new treatments to be developed much faster than by working alone.
It was like clockwork: The moves did not go entirely unnoticed, but Pfizer generally escaped much flak because other pharma companies did the same thing. Days earlier, Pfizer was virtually alone in raising prices for dozens of drugs — many by more than 9 percent — and it prompted a raging tweet from Trump.
In a brief phone call with the president that Read sought on Tuesday night to defuse the uproar, the CEO backed down and deferred the hikes.
Log In Learn More What is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research Subscriber-only networking events and panel discussions across the country Monthly subscriber-only live chats with our reporters and experts in the field Discounted tickets to industry events and early-bird access to industry reports.Current News & Events.
CIT offers full-time, part-time and specialist courses in Art, Business and Humanities, Computing and Information Technology, Engineering, Media, . At Pfizer, we work to make our drug development process more efficient by collaborating with unique partners and exploring new pathways that harness technology and emerging science.
At the core of this work is the belief that collaboration – across organizations, industries and even therapeutic areas – is essential to driving measurable.
Trump tweeted he met with Pfizer CEO Ian Read and Alex Azar, secretary of Health and Human Services, to discuss a “blueprint” for tackling drug prices. Celebrating 10 Years of Progress. Now in its 10th year, CHI’s Immunogenicity & Bioassay Summit will examine the challenges currently facing the industry and will provide NEW case studies, NEW perspectives and NEW approaches.
You will hear from the industry, academia and the regulatory authorities. This year we present 3 Conference Programs, a Symposium, Training Seminar and many .
Jul 10, · The healthcare sector is in the spotlight again due to exorbitant drug pricing. President Donald Trump, in a tweet on Monday, criticized pharmaceutical giant, Pfizer, Inc.
. FBN's Cheryl Casone on Pfizer's plans to reorganize the pharmaceutical company.